Phase II Study of the PD-1 Inhibitor Pembrolizumab for the Treatment of Relapsed or Refractory Mature T-cell Lymphoma
Journal
-
- Clinical Lymphoma Myeloma and Leukemia
-
Clinical Lymphoma Myeloma and Leukemia 19 (6), 356-364.e3, 2019-06
Elsevier BV
- Tweet
Details 詳細情報について
-
- CRID
- 1360298345272028672
-
- ISSN
- 21522650
-
- Data Source
-
- Crossref